Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: Results from two randomized trials

Pierre Van Damme, Geert Leroux-Roels, Philippe Simon, Jean-Michel Foidart, Gilbert Donders, Karel Hoppenbrouwers, Myron Levin, Fabian Tibaldi, Sylviane Poncelet, Philippe Moris, Francis Dessy, Sandra L. Giannini, Dominique Descamps, Gary Dubin
  • Vaccine, June 2014, Elsevier
  • DOI: 10.1016/j.vaccine.2014.03.040

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication


The following have contributed to this page: Gilbert Donders and Professor Geert Leroux-Roels